Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study.

Barbut F, Day N, Bouée S, Youssouf A, Grandvoinnet L, Lalande V, Couturier J, Eckert C.

Clin Microbiol Infect. 2019 May;25(5):588-594. doi: 10.1016/j.cmi.2018.12.024. Epub 2019 Jan 4.

PMID:
30616013
2.

Evaluation of a novel molecular assay to diagnose toxigenic strains of Clostridium difficile.

Eckert C, Devallière T, Syed-Zaidi R, Lalande V, Barbut F.

Anaerobe. 2018 Aug;52:111-114. doi: 10.1016/j.anaerobe.2018.06.012. Epub 2018 Jun 22.

PMID:
29936109
3.

Faecal lactoferrin and calprotectin in patients with Clostridium difficile infection: a case-control study.

Barbut F, Gouot C, Lapidus N, Suzon L, Syed-Zaidi R, Lalande V, Eckert C.

Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2423-2430. doi: 10.1007/s10096-017-3080-y. Epub 2017 Aug 12.

PMID:
28801865
4.

Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.

Sokol H, Lalande V, Landman C, Bourrier A, Nion-Larmurier I, Rajca S, Kirchgesner J, Seksik P, Cosnes J, Barbut F, Beaugerie L.

Dig Liver Dis. 2017 Jun;49(6):643-646. doi: 10.1016/j.dld.2017.01.162. Epub 2017 Jan 30.

PMID:
28215602
5.

Clinical and microbiological determinants of severe and fatal outcomes in patients infected with Enterobacteriaceae producing extended-spectrum β-lactamase.

Surgers L, Boyd A, Boelle PY, Lalande V, Jolivot PA, Girard PM, Arlet G, Cambier C, Homor A, Decre D, Meynard JL.

Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1261-1268. doi: 10.1007/s10096-017-2932-9. Epub 2017 Feb 8.

PMID:
28181033
6.

Clostridium difficile associated reactive arthritis: Case report and literature review.

Legendre P, Lalande V, Eckert C, Barbut F, Fardet L, Meynard JL, Surgers L.

Anaerobe. 2016 Apr;38:76-80. doi: 10.1016/j.anaerobe.2015.12.011. Epub 2015 Dec 30. Review.

PMID:
26743187
7.

Babesiosis and Lyme disease co-infection in a female patient returning from the United States.

Surgers L, Belkadi G, Foucard A, Lalande V, Girard PM, Hennequin C.

Med Mal Infect. 2015 Nov-Dec;45(11-12):490-2. doi: 10.1016/j.medmal.2015.10.002. Epub 2015 Oct 31. No abstract available.

PMID:
26525187
8.

Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus.

Monot M, Eckert C, Lemire A, Hamiot A, Dubois T, Tessier C, Dumoulard B, Hamel B, Petit A, Lalande V, Ma L, Bouchier C, Barbut F, Dupuy B.

Sci Rep. 2015 Oct 8;5:15023. doi: 10.1038/srep15023.

9.

Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.

Le Monnier A, Duburcq A, Zahar JR, Corvec S, Guillard T, Cattoir V, Woerther PL, Fihman V, Lalande V, Jacquier H, Mizrahi A, Farfour E, Morand P, Marcadé G, Coulomb S, Torreton E, Fagnani F, Barbut F; GMC Study Group.

J Hosp Infect. 2015 Oct;91(2):117-22. doi: 10.1016/j.jhin.2015.06.017. Epub 2015 Jul 22.

PMID:
26253518
10.

[Clostridium difficile colitis].

Eckert C, Lalande V, Barbut F.

Rev Prat. 2015 Jan;65(1):21-5. Review. French.

PMID:
25842418
11.

Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B.

Eckert C, Emirian A, Le Monnier A, Cathala L, De Montclos H, Goret J, Berger P, Petit A, De Chevigny A, Jean-Pierre H, Nebbad B, Camiade S, Meckenstock R, Lalande V, Marchandin H, Barbut F.

New Microbes New Infect. 2014 Nov 8;3:12-7. doi: 10.1016/j.nmni.2014.10.003. eCollection 2015 Jan.

12.

In vivo demonstration of magnetic guidewire steerability in a MRI system with additional gradient coils.

Lalande V, Gosselin FP, Vonthron M, Conan B, Tremblay C, Beaudoin G, Soulez G, Martel S.

Med Phys. 2015 Feb;42(2):969-76. doi: 10.1118/1.4906194.

PMID:
25652509
13.

Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.

Regnault H, Bourrier A, Lalande V, Nion-Larmurier I, Sokol H, Seksik P, Barbut F, Cosnes J, Beaugerie L.

Dig Liver Dis. 2014 Dec;46(12):1086-92. doi: 10.1016/j.dld.2014.09.003. Epub 2014 Oct 5.

PMID:
25294795
14.

Report of disseminated Mycobacterium haemophilum infection after double cord blood allo-SCT.

Brissot E, Gomez A, Aline-Fardin A, Lalande V, Lapusan S, Isnard F, Legrand O, Meynard JL, Rubio MT, Mohty M.

Bone Marrow Transplant. 2014 Oct;49(10):1347-8. doi: 10.1038/bmt.2014.144. Epub 2014 Jul 14. No abstract available.

PMID:
25029233
15.

Molecular test based on isothermal helicase-dependent amplification for detection of the Clostridium difficile toxin A gene.

Eckert C, Holscher E, Petit A, Lalande V, Barbut F.

J Clin Microbiol. 2014 Jul;52(7):2386-9. doi: 10.1128/JCM.00353-14. Epub 2014 Apr 23.

16.

Fetal anemia as a signal of congenital syphilis.

Macé G, Castaigne V, Trabbia A, Guigue V, Cynober E, Cortey A, Lalande V, Carbonne B.

J Matern Fetal Neonatal Med. 2014 Sep;27(13):1375-7. doi: 10.3109/14767058.2013.853288. Epub 2013 Nov 7.

PMID:
24134545
17.

Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?

Barbut F, Surgers L, Eckert C, Visseaux B, Cuingnet M, Mesquita C, Pradier N, Thiriez A, Ait-Ammar N, Aifaoui A, Grandsire E, Lalande V.

Clin Microbiol Infect. 2014 Feb;20(2):136-44. doi: 10.1111/1469-0691.12221. Epub 2013 Apr 9.

18.

Evaluation of the chromogenic agar chromID C. difficile.

Eckert C, Burghoffer B, Lalande V, Barbut F.

J Clin Microbiol. 2013 Mar;51(3):1002-4. doi: 10.1128/JCM.02601-12. Epub 2012 Dec 26.

19.

New molecular methods for the diagnosis of Clostridium difficile infections.

Barbut F, Lalande V, Eckert C.

Drugs Today (Barc). 2012 Oct;48(10):673-84. doi: 10.1358/dot.2012.48.10.1864522. Review.

PMID:
23110263
20.

Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum.

Surgers L, Valin N, Carbonne B, Bingen E, Lalande V, Pacanowski J, Meyohas MC, Girard PM, Meynard JL.

Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):107-13. doi: 10.1007/s10096-012-1724-5. Epub 2012 Aug 21.

PMID:
22907333
21.

Accuracy of ICD-10 codes for surveillance of Clostridium difficile infections, France.

Jones G, Taright N, Boelle PY, Marty J, Lalande V, Eckert C, Barbut F.

Emerg Infect Dis. 2012 Jun;18(6):979-81. doi: 10.3201/eid1806.111188.

22.

A MRI-based platform for catheter navigation.

Vonthron M, Lalande V, Martel S.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:5392-5. doi: 10.1109/IEMBS.2011.6091333.

PMID:
22255556
23.

Characterization of the deflections of a catheter steered using a magnetic resonance imaging system.

Gosselin FP, Lalande V, Martel S.

Med Phys. 2011 Sep;38(9):4994-5002. doi: 10.1118/1.3622599.

PMID:
21978043
24.

Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.

Lalande V, Barrault L, Wadel S, Eckert C, Petit JC, Barbut F.

J Clin Microbiol. 2011 Jul;49(7):2714-6. doi: 10.1128/JCM.01835-10. Epub 2011 Apr 27.

25.

Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR.

Barbut F, Monot M, Rousseau A, Cavelot S, Simon T, Burghoffer B, Lalande V, Tankovic J, Petit JC, Dupuy B, Eckert C.

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1279-85. doi: 10.1007/s10096-011-1224-z. Epub 2011 Apr 13.

26.

[Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay].

Lino A, Lalande V, Guetta A, Lebeau B, Heron E, Chouaid C.

Rev Mal Respir. 2011 Mar;28(3):317-21. doi: 10.1016/j.rmr.2011.02.004. Epub 2011 Mar 10. French.

PMID:
21482334
27.

Catheter steering using a Magnetic Resonance Imaging system.

Lalande V, Gosselin FP, Martel S.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:1874-7. doi: 10.1109/IEMBS.2010.5627150.

PMID:
21096567
28.

Safety evaluation of magnetic catheter steering with upgraded magnetic resonance imaging system.

Bringout G, Lalande V, Gosselin FP, Martel S.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:6702-5. doi: 10.1109/IEMBS.2010.5626253.

PMID:
21096080
29.

Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.

Valin N, Pacanowski J, Denoeud L, Lacombe K, Lalande V, Fonquernie L, Girard PM, Meynard JL.

AIDS. 2010 Jun 19;24(10):1519-25.

PMID:
20549841
30.

[Recurrent fever and skin eruption revealing chronic meningococcemia].

Roux M, Sire S, Lalande V, Le Coustumier A, Tiev KP, Tolédano C, Josselin-Mahr L, Gain M, Cabane J, Kettaneh A.

Rev Med Interne. 2010 Jun;31(6):445-8. doi: 10.1016/j.revmed.2009.11.010. Epub 2010 Apr 14. French.

PMID:
20395022
31.

Human intestinal microbiota gene risk factors for antibiotic-associated diarrhea: perspectives for prevention. Risk factors for antibiotic-associated diarrhea.

de La Cochetière MF, Montassier E, Hardouin JB, Carton T, Le Vacon F, Durand T, Lalande V, Petit JC, Potel G, Beaugerie L.

Microb Ecol. 2010 May;59(4):830-7. doi: 10.1007/s00248-010-9637-2. Epub 2010 Feb 26.

32.

Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality?

Baudel JL, Tankovic J, Carrat F, Vigneau C, Maury E, Lalande V, Guidet B, Offenstadt G.

Ther Clin Risk Manag. 2009 Jun;5(3):491-8. Epub 2009 Jul 12.

33.

Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR.

Barbut F, Braun M, Burghoffer B, Lalande V, Eckert C.

J Clin Microbiol. 2009 Apr;47(4):1276-7. doi: 10.1128/JCM.00309-09. Epub 2009 Feb 25. No abstract available.

34.

Campylobacter bacteremia: clinical features and factors associated with fatal outcome.

Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P, Trystram D, Kassis N, Arlet G, Mainardi JL, Doucet-Populaire F, Girard PM, Meynard JL; CAMPYL Study Group.

Clin Infect Dis. 2008 Sep 15;47(6):790-6. doi: 10.1086/591530.

PMID:
18699745
35.

Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile.

De La Cochetière MF, Durand T, Lalande V, Petit JC, Potel G, Beaugerie L.

Microb Ecol. 2008 Oct;56(3):395-402. doi: 10.1007/s00248-007-9356-5. Epub 2008 Jan 22.

36.

[Pulmonary infections with Mycobacterium xenopi in patients without HIV infection].

Dixmier A, Meynard JL, Lalande V, Lebeau B, Chouaïd C.

Rev Mal Respir. 2007 Mar;24(3 Pt 1):299-304. French.

PMID:
17417167
37.

Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.

Barbut F, Gariazzo B, Bonné L, Lalande V, Burghoffer B, Luiuz R, Petit JC.

Infect Control Hosp Epidemiol. 2007 Feb;28(2):131-9. Epub 2007 Jan 24.

PMID:
17265393
38.

A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis.

Dautremer J, Pacanowski J, Girard PM, Lalande V, Sivignon F, Meynard JL.

AIDS. 2007 Jan 30;21(3):381-2. No abstract available.

PMID:
17255750
39.

Outbreak of Ralstonia pickettii pseudobacteremia among patients with hematological malignancies.

Barbut F, Kosmann MJ, Lalande V, Neyme D, Coppo P, Gorin NC.

Infect Control Hosp Epidemiol. 2006 Jun;27(6):642-4. No abstract available.

PMID:
16755490
40.

Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002.

Valin N, Antoun F, Chouaïd C, Renard M, Dautzenberg B, Lalande V, Ayache B, Morin P, Sougakoff W, Thiolet JM, Truffot-Pernot C, Jarlier V, Decludt B.

Int J Tuberc Lung Dis. 2005 May;9(5):528-33.

PMID:
15875924
41.

Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate.

Hidri N, Barnaud G, Decré D, Cerceau C, Lalande V, Petit JC, Labia R, Arlet G.

J Antimicrob Chemother. 2005 Apr;55(4):496-9. Epub 2005 Feb 18.

PMID:
15722393
42.

Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains.

Barbut F, Decré D, Lalande V, Burghoffer B, Noussair L, Gigandon A, Espinasse F, Raskine L, Robert J, Mangeol A, Branger C, Petit JC.

J Med Microbiol. 2005 Feb;54(Pt 2):181-5.

PMID:
15673514
43.

[The use of microbiological tools for the diagnosis of nosocomial pulmonary infections].

Deschamps C, Lacombe K, Lalande V, Meyohas MC, Girard PM, Meynard JL.

Presse Med. 2004 Dec 4;33(21):1505-10. French.

PMID:
15614172
44.

[Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].

Barbut F, Soukouna S, Lalande V, Garcia ML, Neyme D, de Gramont A, Petit JC.

Pathol Biol (Paris). 2004 Dec;52(10):566-74. French.

PMID:
15596304
45.

A European survey of diagnostic methods and testing protocols for Clostridium difficile.

Barbut F, Delmée M, Brazier JS, Petit JC, Poxton IR, Rupnik M, Lalande V, Schneider C, Mastrantonio P, Alonso R, Kuipjer E, Tvede M; ESCMID Study Group on Clostridium difficile (ESGCD).

Clin Microbiol Infect. 2003 Oct;9(10):989-96.

46.

Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics.

Meynard JL, Guiguet M, Fonquernie L, Lefebvre B, Lalande V, Honore I, Meyohas MC, Girard PM.

HIV Med. 2003 Apr;4(2):127-32.

47.

Antibiotic-associated diarrhoea and Clostridium difficile in the community.

Beaugerie L, Flahault A, Barbut F, Atlan P, Lalande V, Cousin P, Cadilhac M, Petit JC; Study Group.

Aliment Pharmacol Ther. 2003 Apr 1;17(7):905-12.

48.

Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.

Barbut F, Lalande V, Burghoffer B, Thien HV, Grimprel E, Petit JC.

J Clin Microbiol. 2002 Jun;40(6):2079-83.

49.

Pseudo-outbreak of Mycobacterium gordonae associated with water from refrigerated fountains.

Lalande V, Barbut F, Varnerot A, Febvre M, Nesa D, Wadel S, Vincent V, Petit JC.

J Hosp Infect. 2001 May;48(1):76-9.

PMID:
11358474
50.

Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated diseases.

Barbut F, Lalande V, Daprey G, Cohen P, Marle N, Burghoffer B, Petit JC.

Eur J Clin Microbiol Infect Dis. 2000 Jun;19(6):481-4.

PMID:
10947228

Supplemental Content

Loading ...
Support Center